2025 Scottsdale Headache Symposium On Demand

Since the inaugural meeting in 1970, the Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management and treatment of headache patients. Education is presented in didactic, case-based, evidence-based, panel and demonstrative formats over the course of four days.

Course Instructions

Live meeting attendees who joined us in Scottsdale have complimentary access to the recorded content within this course. AHS members should login using their membership credentials, and all others can create a new Visitor account or login as a Visitor using their existing visitor credentials. Once logged in, click "Take Course" to access recorded content, complete the meeting evaluation, and claim CME.

Target Audience

This symposium is designed for general practitioners, internists, pediatricians, neurologists, anesthesiologists, dentists, physical therapists, psychologists, psychiatrists, nurse practitioners, physician assistants, nurses, and other health professionals who treat headache.

Learning Objectives

At the conclusion of the American Headache Society’s 2025 Scottsdale Headache Symposium, participants will be able to:

  • Apply knowledge of the diagnosis, epidemiology, and treatment of primary headache disorders in adults and children in clinical practice and research
  • Evaluate emerging clinical trial data and pipeline therapies to inform evidence-based treatment decisions for migraine.
  • Optimize patient outcomes with focused history-taking and effective communication strategies including motivational interviewing.
  • Assess the real-world data for the efficacy and safety of neuromodulation therapies for primary headache disorders
Course summary
Available credit: 
  • 35.25 AMA PRA Category 1 Credit™
  • 35.25 Participation
Course opens: 
12/23/2025
Course expires: 
06/24/2026
Cost:
$1,000.00

Disclosure Information

The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

PURPOSE/OBJECTIVE

At the conclusion of the American Headache Society’s 2025 Scottsdale Headache Symposium, participants will be able to apply knowledge of the diagnosis, epidemiology, and treatment of primary headache disorders in adults and children in clinical practice and research, evaluate emerging clinical trial data and pipeline therapies to inform evidence-based treatment decisions for migraine, optimize patient outcomes with focused history-taking and effective communication strategies including motivational interviewing, and assess the real-world data for the efficacy and safety of neuromodulation therapies for primary headache disorders.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this enduring material for a maximum of 35.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME:

  • Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Scottsdale Headache Symposium).
  • Watch all recorded sessions for which credit is sought.
  • Complete the post-activity evaluation.
  • Enter the number of CME credits being claimed*.
  • Download your certificate.

*Please note: The maximum number of credits is calculated based on watching all recorded sessions within this course. View CME hours per session on the program here.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received funding for this activity from the following organizations:

AbbVie Inc.
Axsome Therapeutics
Lundbeck LLC.
Pfizer Inc.

The American Headache Society received an in-kind donation of migraine units (heads) for the Injection Training Workshop from the following organizations:

AbbVie Inc.

BIBLIOGRAPHY

References are included at the end of the presentations.

Available Credit

  • 35.25 AMA PRA Category 1 Credit™
  • 35.25 Participation

Price

Cost:
$1,000.00
Please login or register to take this course.


Live Meeting Attendees

Click "Take course" above to watch any recorded presentations for which credit is sought prior to completing the evaluation and claiming CME. 

Non-meeting Attendees

Please add the course to your cart and checkout to access content. Discount codes are available for Active Military Personnel and Non-member Trainees. Contact us for information!